- List
- By Topic
- On Map
- Search Details

dronabinol OR tetrahydronnabinol OR marinol
Need help? See RSS Feeds
Choose a feed type:

dronabinol OR tetrahydronnabinol OR marinol (197 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03066193 | Recruiting | Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome |
|
|
Interventional | Phase 3 |
|
Other |
|
|
18 | All | 18 Years to 60 Years (Adult) | NCT03066193 | 1610018525 | February 1, 2017 | January 2018 | January 2019 | February 28, 2017 | March 3, 2017 |
|
||
2 | NCT02569073 | Recruiting | Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain |
|
|
Interventional | Phase 4 |
|
Other |
|
|
40 | All | 18 Years to 75 Years (Adult, Senior) | NCT02569073 | 22894 | ICAMP | June 21, 2017 | October 2018 | October 2020 | October 6, 2015 | July 31, 2017 |
|
|
3 | NCT02792257 | Recruiting | Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease (AD) (THC-AD) |
|
|
Interventional | Phase 2 |
|
Other |
|
|
160 | All | 60 Years to 90 Years (Adult, Senior) | NCT02792257 | IRB00052955 | THC-AD | March 1, 2017 | August 2020 | December 2020 | June 7, 2016 | October 27, 2017 |
|
|
4 | NCT02608931 | Recruiting | The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial Dysautonomia |
|
|
Interventional | Phase 2 |
|
Other |
|
|
25 | All | 18 Years to 60 Years (Adult) | NCT02608931 | 14-01577 | November 2015 | March 2018 | March 2018 | November 20, 2015 | November 22, 2017 |
|
||
5 | NCT02460692 | Recruiting | Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
120 | All | 19 Years to 70 Years (Adult, Senior) | NCT02460692 | 1R01DA038634-01A1 R01DA038634 |
September 2016 | May 2020 | May 2020 | June 2, 2015 | September 19, 2017 |
|
||
6 | NCT02604992 | Completed | Comparative Bioavailability of Dronabinol Oral Solution in Healthy Volunteers |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
54 | All | 18 Years to 50 Years (Adult) | NCT02604992 | INS004-15-059 | November 2015 | December 2015 | December 2015 | November 16, 2015 | January 20, 2016 |
|
||
7 | NCT02811510 | Recruiting | Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I |
|
|
Interventional | Phase 1 |
|
Other |
|
|
40 | All | 18 Years to 55 Years (Adult) | NCT02811510 | 1505015940.A | THC-Gender-I | June 2016 | June 2020 | June 2020 | June 23, 2016 | February 23, 2017 |
|
|
8 | NCT03215940 | Recruiting | Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC) |
|
|
Interventional | Early Phase 1 |
|
Other |
|
|
75 | All | 18 Years to 50 Years (Adult) | NCT03215940 | IRB_00103451 | February 1, 2018 | December 2018 | February 2019 | July 12, 2017 | February 23, 2018 |
|
||
9 | NCT01598896 | Recruiting | Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
18 | All | 18 Years to 45 Years (Adult) | NCT01598896 | 2010P-002262 Brain and Behavior Research |
DCCS | May 2012 | August 2017 | August 2017 | May 15, 2012 | April 27, 2017 |
|
|
10 | NCT01394185 | Completed Has Results |
Effects of Dronabinol (Oral THC) on Cannabis Use |
|
|
Interventional | Phase 1 Phase 2 |
|
Other / NIH |
|
|
25 | All | 18 Years to 100 Years (Adult, Senior) | NCT01394185 | NA_00041251 R01DA025044 |
February 2011 | September 2012 | September 2012 | July 14, 2011 | August 3, 2017 | August 3, 2017 |
|
|
11 | NCT02094599 | Completed | A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
43 | All | 18 Years to 55 Years (Adult) | NCT02094599 | INS-13-017 | February 2014 | May 2014 | May 2014 | March 24, 2014 | May 13, 2014 |
|
||
12 | NCT03098940 | Not yet recruiting | A Bioavailability Study on Dronabinol |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
50 | All | 18 Years to 55 Years (Adult) | NCT03098940 | MedChew | January 2018 | April 2018 | September 2018 | April 4, 2017 | April 4, 2017 | |||
13 | NCT01380457 | Completed | Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions |
|
|
Interventional | Phase 1 |
|
Industry / Other |
|
|
69 | All | 18 Years to 55 Years (Adult) | NCT01380457 | 11885 | January 2006 | April 2006 | April 2006 | June 27, 2011 | June 27, 2011 |
|
||
14 | NCT03008005 | Recruiting | Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study |
|
|
Interventional | Phase 4 |
|
Other |
|
|
104 | All | 18 Years to 50 Years (Adult) | NCT03008005 | 1R61MH111935-01 | June 1, 2017 | December 31, 2019 | December 31, 2019 | January 2, 2017 | November 6, 2017 |
|
||
15 | NCT01093976 | Completed Has Results |
Marinol in Trichotillomania or Obsessive Compulsive Disorder |
|
|
Interventional | Phase 2 |
|
Other |
|
|
14 | All | 18 Years to 65 Years (Adult) | NCT01093976 | 0909M72088 | April 2010 | January 2011 | February 2011 | March 26, 2010 | September 27, 2013 | September 27, 2013 |
|
|
16 | NCT02472847 | Completed Has Results |
Cannabinoid Control of Fear Extinction Neural Circuits in Humans |
|
|
Interventional | Phase 4 |
|
Other / NIH |
|
|
85 | All | 21 Years to 45 Years (Adult) | NCT02472847 | 2012-0242 R21MH093917 |
May 2012 | July 2014 | July 2014 | June 16, 2015 | August 25, 2015 | August 25, 2015 | ||
17 | NCT01448772 | Completed | Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
88 | All | 18 Years to 55 Years (Adult) | NCT01448772 | INS-10-012 | October 2011 | December 2011 | December 2011 | October 7, 2011 | March 26, 2012 |
|
||
18 | NCT01024335 | Completed Has Results |
Dronabinol Naltrexone Treatment for Opioid Dependence |
|
|
Interventional | Phase 2 Phase 3 |
|
Other / NIH |
|
|
60 | All | 18 Years to 60 Years (Adult) | NCT01024335 | #5962 DA027124 R01DA027124 DPMC |
Domino | January 2010 | December 2012 | December 2012 | December 2, 2009 | September 5, 2014 | September 5, 2014 |
|
19 | NCT00959218 | Completed | Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple Sclerosis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
240 | All | 18 Years to 70 Years (Adult, Senior) | NCT00959218 | cnp-MS-0601 / MC-2006-01 | June 2007 | March 2010 | April 2010 | August 14, 2009 | February 3, 2012 |
|
||
20 | NCT01020019 | Completed Has Results |
Combined Pharmacotherapy for Cannabis Dependency |
|
|
Interventional | Phase 2 Phase 3 |
|
Other / NIH |
|
|
156 | All | 18 Years to 60 Years (Adult) | NCT01020019 | #6015 P50DA009236-16 |
D-LUCS | January 2010 | September 2014 | September 2014 | November 25, 2009 | April 6, 2018 | May 11, 2016 |
|
21 | NCT02811939 | Recruiting | Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I |
|
|
Interventional | Phase 1 |
|
Other |
|
|
19 | All | 18 Years to 55 Years (Adult) | NCT02811939 | 1501015242.A | THC-PREG-I | March 2016 | February 2018 | February 2018 | June 23, 2016 | June 23, 2017 |
|
|
22 | NCT03369639 | Recruiting | Study of Dronabinol Treatment for Depression and/or Anxiety in Older Patients |
|
Observational |
|
Other |
|
|
45 | All | 50 Years to 89 Years (Adult, Senior) | NCT03369639 | 2017P001930 | November 28, 2017 | January 1, 2019 | September 1, 2019 | December 12, 2017 | December 12, 2017 |
|
||||
23 | NCT02069366 | Recruiting | Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder |
|
|
Interventional | Not Applicable |
|
Other |
|
|
120 | All | 21 Years to 45 Years (Adult) | NCT02069366 | 1K01MH101123-01A1 | November 2014 | March 2018 | February 24, 2014 | December 7, 2016 |
|
|||
24 | NCT01832766 | Terminated Has Results |
The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
13 | All | 18 Years to 50 Years (Adult) | NCT01832766 | 05-0359 | June 2005 | May 2010 | May 2011 | April 16, 2013 | September 21, 2015 | September 21, 2015 |
|
|
25 | NCT00946348 | Completed Has Results |
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment |
|
|
Interventional | Phase 1 |
|
Other / NIH |
|
|
12 | All | 18 Years to 50 Years (Adult) | NCT00946348 | R01DA013196 1R01DA026799-01 R01DA026799-01 DPMC |
December 2009 | October 2012 | October 2012 | July 27, 2009 | March 14, 2018 | September 29, 2014 |
|
|
26 | NCT00480441 | Completed | Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
61 | All | 18 Years to 55 Years (Adult) | NCT00480441 | 5P60DA005186-19 | August 2006 | June 2009 | July 2009 | May 31, 2007 | January 18, 2012 |
|
||
27 | NCT01253408 | Completed Has Results |
Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS) |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
36 | All | 18 Years to 75 Years (Adult, Senior) | NCT01253408 | 08-008314 Part A R01DK079866 UL1RR024150 |
September 2009 | December 2011 | December 2011 | December 3, 2010 | May 7, 2013 | May 7, 2013 |
|
|
28 | NCT00217971 | Completed Has Results |
Dronabinol Treatment for Marijuana Addiction |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
156 | All | 18 Years to 60 Years (Adult) | NCT00217971 | #4886-NIDA-09236-11 P50DA009236 P50DA009236-11 DPMC |
MARINOL | March 2005 | December 2009 | December 2009 | September 22, 2005 | April 8, 2016 | November 1, 2011 |
|
29 | NCT00418925 | Unknown † | Efficacy of Dronabinol for the Treatment of Cervical Dystonia |
|
|
Interventional | Phase 2 |
|
Other |
|
|
38 | All | 18 Years to 75 Years (Adult, Senior) | NCT00418925 | MDC DRO 2006 | September 2006 | November 2009 | December 2009 | January 5, 2007 | September 9, 2008 |
|
||
30 | NCT00314808 | Completed Has Results |
A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
33 | All | 18 Years and older (Adult, Senior) | NCT00314808 | Pro00007559 7136-05-6R0 |
April 2006 | October 2011 | April 2012 | April 17, 2006 | July 16, 2014 | August 6, 2013 |
|
|
31 | NCT01149018 | Unknown † | Efficacy Trial of Oral Tetrahydrocannabinol in Patients With Fibromyalgia |
|
|
Interventional | Not Applicable |
|
Other |
|
|
80 | All | 18 Years and older (Adult, Senior) | NCT01149018 | THC-FMS-HMO-CTIL | June 2010 | July 2012 | October 2012 | June 23, 2010 | June 23, 2010 |
|
||
32 | NCT02576912 | Recruiting | Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone |
|
|
Interventional | Phase 1 |
|
Other |
|
|
19 | All | 18 Years to 55 Years (Adult) | NCT02576912 | 1501015242 | THC-Preg | February 2015 | December 2017 | December 2017 | October 15, 2015 | June 23, 2017 |
|
|
33 | NCT00842985 | Completed Has Results |
Dronabinol Interactions With Cognitive Enhancing Drug in Humans |
|
|
Interventional | Early Phase 1 |
|
Other / U.S. Fed / NIH |
|
|
53 | All | 18 Years to 55 Years (Adult) | NCT00842985 | 0702002357 MIRECC 00000000 P50DA009241 |
September 2008 | October 2009 | October 2009 | February 12, 2009 | May 30, 2017 | December 17, 2012 |
|
|
34 | NCT00153192 | Completed | Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic Pain |
|
|
Interventional | Phase 2 Phase 3 |
|
Other / Industry |
|
|
30 | All | Child, Adult, Senior | NCT00153192 | 2001-P-000474 BN7894973 |
April 2001 | April 2006 | April 2006 | September 12, 2005 | April 26, 2013 |
|
||
35 | NCT00490269 | Completed Has Results |
Ph1 Marinol Interaction Study - Part 2 - 1 |
|
|
Interventional | Phase 1 |
|
NIH |
|
|
12 | All | 18 Years to 45 Years (Adult) | NCT00490269 | NIDA-CPU-0013-1 | October 2006 | December 2007 | December 2007 | June 22, 2007 | January 12, 2017 | April 8, 2013 |
|
|
36 | NCT01755091 | Completed Has Results |
Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea |
|
|
Interventional | Phase 2 |
|
Other |
|
|
75 | All | 21 Years to 64 Years (Adult) | NCT01755091 | UM1HL112856 2011-06400 UM1HL112856 |
PACE | February 2013 | June 2016 | December 31, 2016 | December 21, 2012 | December 22, 2017 | December 22, 2017 |
|
37 | NCT03206463 | Not yet recruiting | Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder |
|
|
Interventional | Phase 1 |
|
Other |
|
|
40 | All | 18 Years to 55 Years (Adult) | NCT03206463 | 2000020272 | THC-BD | July 2017 | July 2019 | July 2019 | July 2, 2017 | July 2, 2017 |
|
|
38 | NCT02492074 | Not yet recruiting | Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study |
|
|
Interventional | Phase 1 |
|
Other |
|
|
60 | Male | 18 Years to 45 Years (Adult) | NCT02492074 | GEI-TCP I | April 2019 | April 2020 | May 2020 | July 8, 2015 | March 15, 2018 |
|
||
39 | NCT00438139 | Terminated | Ph1 Marinol Interaction Study - Part 1 - 1 |
|
|
Interventional | Phase 1 |
|
NIH |
|
|
6 | All | 18 Years to 45 Years (Adult) | NCT00438139 | NIDA-CPU-0011-1 | March 2007 | March 2007 | March 2007 | February 21, 2007 | January 16, 2017 |
|
||
40 | NCT01964404 | Recruiting | Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? |
|
|
Interventional | Phase 1 |
|
Other |
|
|
240 | All | 18 Years to 55 Years (Adult) | NCT01964404 | 1R01DA034699-01A1 | July 2014 | March 2020 | April 2020 | October 17, 2013 | March 23, 2018 |
|
||
41 | NCT00743119 | Completed Has Results |
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
34 | Female | 21 Years to 45 Years (Adult) | NCT00743119 | 5603 5P50DA009236 |
June 2008 | October 2009 | May 2013 | August 28, 2008 | December 11, 2017 | December 11, 2017 |
|
|
42 | NCT02335060 | Active, not recruiting | N-acetylcysteine Effects on Tetrahydrocannabinol |
|
|
Interventional | Phase 1 |
|
Other |
|
|
36 | All | 18 Years to 55 Years (Adult) | NCT02335060 | 1402013406 | March 2014 | January 2019 | January 2019 | January 9, 2015 | April 26, 2017 |
|
||
43 | NCT00642499 | Completed | Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
103 | All | 18 Years to 70 Years (Adult, Senior) | NCT00642499 | S175.2.101 | August 2003 | April 2005 | April 2005 | March 25, 2008 | April 2, 2008 |
|
||
44 | NCT00553059 | Completed | Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer |
|
|
Interventional | Phase 3 |
|
Other / NIH / Industry |
|
|
62 | All | 18 Years and older (Adult, Senior) | NCT00553059 | 2006-0841 MDA-2006-0841 CDR0000573510 NCI-2009-00637 |
May 2008 | August 2014 | November 5, 2007 | September 5, 2014 |
|
|||
45 | NCT01893424 | Completed | Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol) |
|
|
Interventional | Phase 1 |
|
Other |
|
|
12 | Male | 18 Years to 45 Years (Adult) | NCT01893424 | 0658-12-HMO-CTIL | August 2013 | January 2014 | January 2015 | July 9, 2013 | March 24, 2016 |
|
||
46 | NCT00760695 | Completed | Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia Nervosa |
|
|
Interventional | Phase 3 |
|
Other |
|
|
24 | All | 18 Years and older (Adult, Senior) | NCT00760695 | 033 | October 2008 | December 2011 | December 2011 | September 26, 2008 | May 10, 2013 |
|
||
47 | NCT00316563 | Completed | Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study |
|
|
Interventional | Phase 2 |
|
Other |
|
|
80 | All | 18 Years and older (Adult, Senior) | NCT00316563 | PS-8-0008 | August 2006 | November 2009 | April 21, 2006 | February 9, 2010 |
|
|||
48 | NCT00123201 | Completed | Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache |
|
|
Interventional | Phase 2 |
|
Industry |
|
All | 18 Years to 65 Years (Adult) | NCT00123201 | S175.2.103 | September 2005 | March 2007 | March 2007 | July 22, 2005 | January 16, 2015 |
|
||||
49 | NCT02291536 | Completed | Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | Male | 18 Years to 65 Years (Adult) | NCT02291536 | AB_THC_CBD | AB_THC_CBD | February 2014 | December 2014 | December 2014 | November 14, 2014 | January 16, 2015 |
|
|
50 | NCT00757822 | Completed Has Results |
Prevention of Postoperative Nausea and Vomiting (PONV) in Surgical Patients |
|
|
Interventional | Not Applicable |
|
U.S. Fed |
|
|
216 | All | 18 Years and older (Adult, Senior) | NCT00757822 | CLIN-008-08S 0167_2008I |
PONV | December 2009 | December 2013 | April 2015 | September 23, 2008 | May 13, 2016 | May 13, 2016 |
|
† Study has passed its completion date and status has not been verified in more than two years.